24/7 Customer Support
Global Ultrasound Devices Market was valued at US$ 7,197.7 million in 2022 and is projected to reach US$ 10,919.6 million by 2031 at a CAGR of 4.74% during the forecast period 2023–2030.
Ultrasound devices have long been a mainstay in the medical imaging landscape, with their utility spanning a myriad of clinical applications. Over the years, the global ultrasound devices market has grown and evolved, shaped by technological advancements, shifting patient demographics, and the overarching trends of healthcare industries across regions. In recent times, the market landscape for ultrasound devices has been characterized by a surge in the adoption of portable and handheld devices, primarily due to their convenience and applicability in various point-of-care settings. Historically, these devices found significant use in obstetrics and gynecology, but today their reach extends to cardiology, radiology, and even emergency medicine.
Several developments are propelling this market forward such as 3D and 4D imaging have opened up new vistas for ultrasound imaging, providing clinicians with a more detailed and holistic view of the area under observation. Additionally, there has been a rise in public and private investments in healthcare infrastructures, especially in emerging economies. For instance, according to a recent survey, in 2022, healthcare investments in the Asia-Pacific ultrasound devices market surpassed $70 billion, a sizable chunk of which was directed towards diagnostic imaging. The dynamics of the market have also been influenced by the behaviors of its end users. With the global geriatric population on the rise, there has been a surge in the demand for diagnostic procedures. It's estimated that by 2050, the global population of individuals aged 60 and over will reach 2 billion. This demographic shift underscores the importance of efficient and non-invasive diagnostic tools, a niche where ultrasound devices excel.
Key consumers for ultrasound devices, primarily hospitals and diagnostic centers, are leaning towards devices that offer versatility, precision, and, increasingly, connectivity. The latter trend, in particular, is driven by the broader digital transformation of healthcare, where telemedicine and remote consultations have become more prevalent. Data suggests that as of 2021, 65% of hospitals in developed nations had integrated at least one form of tele-ultrasound solution into their diagnostics arsenal.
Looking ahead, the future of the ultrasound devices market appears bright, with several trends and opportunities on the horizon. Artificial Intelligence (AI) integration, for instance, promises to revolutionize ultrasound imaging, offering enhanced image quality, real-time analytics, and personalized patient insights. Preliminary trials have shown that AI-enhanced ultrasound can increase diagnostic accuracy by up to 15% in certain cases.
To Get more Insights, Request A Free Sample
Technological leaps in the ultrasound devices market have spurred substantial market growth. The advent of 3D and 4D imaging techniques has changed the diagnostic landscape. Our study indicates that hospitals and clinics using 4D imaging techniques increased their patient diagnosis accuracy rates by 12% compared to the conventional 2D imaging. This shift resulted in a 6.5% year-on-year revenue increase for manufacturers specializing in 3D and 4D ultrasound devices. Further study reveal that hospitals adopting these advanced imaging techniques saw a 9% increase in patient referrals, showcasing their growing prominence and reliability in the medical community.
The PoCUS trend is changing how medical practitioners approach emergency care. A survey conducted across major hospitals in Europe and North America in 2022 highlighted that 68% of medical emergencies benefited from immediate PoCUS interventions, leading to faster decision-making. This shift towards PoCUS has also impacted the market dynamics. While the global ultrasound devices market grew at 4.74% in 2022, the PoCUS sub-segment outpaced it with a growth rate of 12%. Furthermore, the reduced cost of training, with an average 15% reduction in training programs from 2019 to 2022, indicates a broader acceptance and integration of PoCUS in medical curricula.
The synergy of AI and ultrasound holds transformative potential. Preliminary studies of the global ultrasound devices market in 2022 indicated that AI-enhanced ultrasounds led to a 25% reduction in false positives compared to traditional ultrasounds, enhancing diagnostic reliability. Investment data reveals a corresponding bullish sentiment. From a modest $200 million global investment in AI-ultrasound integrative technologies in 2019, the figures soared to $700 million in 2022, marking a 250% increase. Additionally, AI-integrated ultrasound devices are expected to dominate the market share by 2030, capturing an estimated 40% of the total ultrasound market. A research projection indicates that by 2030, 75% of ultrasound devices could be AI-enhanced, highlighting a compound annual growth rate (CAGR) of approximately 17% over eight years.
As the ultrasound devices market burgeons with innovations, it is simultaneously encountering challenges, particularly from stringent regulatory environments. One specific challenge is the complex approval process for new ultrasound modalities, especially those integrating artificial intelligence and advanced imaging techniques. In 2021, for example, the U.S. FDA updated its guidelines for the approval of AI-enhanced medical devices, leading to prolonged validation periods. As a result, several manufacturers faced delays of up to 18 months for their product approvals compared to the average 6–9-month timeline experienced previously. The European Union, following the implementation of the Medical Device Regulation (MDR) in 2020, similarly witnessed a backlog in device approvals. For ultrasound devices employing new modalities or AI integrations, the approval rate decreased by 12% in 2021 compared to the preceding year.
These regulatory challenges in the global ultrasound devices market have direct financial implications for manufacturers. A report from 2022 indicates that companies entering the advanced ultrasound market had to allocate an additional 15% of their budgets towards regulatory compliance, directly impacting the speed of innovation and market entry. This regulatory stringency, while ensuring patient safety and product efficacy, places an additional burden on manufacturers, slowing down the time-to-market for cutting-edge devices, and limiting the immediate availability of potentially life-saving innovations for patients.
In terms of technology, diagnostic ultrasound overwhelmingly dominates the ultrasound devices market with an impressive 92.4% market share. This vast segment has been forecasted to grow at a CAGR of 4.83%, which is testament to its foundational role in medical diagnostics. One of the drivers of this significant market share can be attributed to its diverse applications across various medical domains like oncology, cardiology, and obstetrics. With advancements in ultrasound resolution and imaging techniques, diagnostic ultrasounds are increasingly used for tumor detection, cardiac anomaly screenings, and prenatal monitoring. The rising prevalence of lifestyle-related illnesses, which often require non-invasive diagnostic measures, further fuels the demand for this technology. As societies grapple with health challenges like cardiovascular diseases and cancers, the indispensability of diagnostic ultrasounds becomes even more pronounced, accounting for its anticipated accelerated growth in the coming years.
By display type, color ultrasound devices, as opposed to their black-and-white counterparts, have seen a meteoric rise in demand, capturing a substantial 90.90% of the share of the global ultrasound devices market in 2022. These devices, leveraging advanced visualization techniques, offer clinicians a more detailed and nuanced view of the area under observation. With the projection that its market share will further burgeon to approximately 92.2% by 2030, this surge underscores the medical community's shifting preference towards color ultrasound devices. Enhanced image clarity, better differentiation between soft tissues, and improved blood flow visualization are some of the factors underpinning this trend. As medical diagnostics increasingly demand precision and clarity, color ultrasound devices will undoubtedly continue their market ascent.
Portability plays a significant role in the modern medical world, with cart/trolley-based ultrasound devices claiming a dominant 57.31% market share in 2022. These devices bring unparalleled convenience to medical practitioners. In critical care settings like ICUs and emergency rooms, where time is of the essence and patient mobility can be challenging, cart/trolley-based ultrasounds prove invaluable. By allowing diagnostic equipment to be easily wheeled to a patient's bedside, they negate the need for patient relocation, which can sometimes be risky. This not only expedites the diagnostic process but also ensures prompt treatment initiation, culminating in better patient outcomes and satisfaction levels.
On the application front, Radiology/General Imaging leads the ultrasound devices market, capturing a notable 29.63% of the market share in 2022. This dominance can be attributed to the increasing demand for non-invasive imaging techniques across various healthcare facilities globally. Radiology, as a discipline, has become central to the diagnostic process in most illnesses, ranging from bone fractures to complex soft tissue anomalies. With the projection that its market share will further ascend to 31.19% by 2030, this upward trajectory is emblematic of radiology's growing significance in medical diagnostics. As healthcare moves towards precision medicine, and as populations age, the need for comprehensive imaging solutions, like those offered by ultrasound devices in radiology, will likely intensify.
To Understand More About this Research: Request A Free Sample
Asia Pacific is expected to register the most robust growth at a CAGR of 5.18% and by 2030, will consolidate its position as the second-largest player in the global ultrasound devices market, controlling over 29.41% of the global share. Several factors feed into this growth trajectory. The region is home to approximately 60% of the world's population, a statistic that in itself presents a vast market for healthcare solutions. Countries like India are witnessing a demographic transition, with its burgeoning middle class increasingly accessing healthcare services. The Asian Development Bank reported a 9.7% increase in per capita health expenditure across major APAC nations from 2015 to 2022. Wherein, China, a major player in the Asia Pacific region, encapsulates this growth story. The country, with its 1.4 billion population, represents a significant chunk of the region's ultrasound market. Chinese Government data reveals a 15% increase in healthcare expenditure between 2019 and 2022. Alongside, China's commitment to bolstering its primary healthcare system is palpable. With policies prioritizing early detection and management of chronic diseases, the demand for diagnostic tools like ultrasound devices is on a sharp rise.
North America & Europe are mature ultrasound devices market and their growth can be attributed to the prevalence of chronic and life-threatening diseases, which demand investigational procedures. A study from the American Heart Association (2022) highlighted that nearly half of the U.S. adult population has some form of cardiovascular disease, to be precise, affects around 121 million americans. This necessitates advanced diagnostic methods, placing ultrasound devices in the spotlight. In Europe, the rise in conditions like osteoporosis, especially in countries like Spain and Italy with older populations, has spurred the ultrasound devices market.
South America & Middle East and Africa, though currently not at the forefront of the ultrasound devices market, are slowly carving their niche. The growth rate, though marginal, hints at untapped potential. South America, with countries like Brazil and Argentina ramping up healthcare infrastructure, is witnessing a 3% year-on-year increase in ultrasound device imports. The Middle East and Africa, with its unique blend of affluent nations and developing economies, saw a 2.4% increase in healthcare diagnostics expenditure in 2021. As these regions grapple with both infectious and non-infectious diseases, the applicability and versatility of ultrasound devices could act as catalysts for growth in the coming years.
By Display Type
By End User
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.SPEAK TO AN ANALYST